An image of a smartphone and a pen
Markets

Spears Abacus Advisors LLC Buys iShares Nasdaq Biotechnology Index Fund, Kellogg Co, ...

Spears Abacus Advisors LLC

  • New Purchases: IBB , K , KMB , GXP, MJN, WETF, VIAB, VIG, TIP, TAHO,
  • Added Positions:HSY, UNH, JNJ, SPY, IWF, VZ, BRK.B, XLF, WFC, VEU,
  • Reduced Positions:AGN, AIG, CB, DLPH, CMCSA, TMO, DHR, CIT, MET, JPM,
  • Sold Out:ABT, RHI, NCLH, RCL, AMX, BBBY, LUX, SPGI, WSM,

For the details of Spears Abacus Advisors LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Spears+Abacus+Advisors+LLC

These are the top 5 holdings of Spears Abacus Advisors LLC

  1. Chubb Ltd ( CB ) - 336,451 shares, 5.71% of the total portfolio. Shares reduced by 7.72%
  2. General Electric Co ( GE ) - 1,211,343 shares, 4.92% of the total portfolio. Shares reduced by 2.86%
  3. American International Group Inc ( AIG ) - 580,465 shares, 4.87% of the total portfolio. Shares reduced by 9.7%
  4. Thermo Fisher Scientific Inc ( TMO ) - 262,629 shares, 4.76% of the total portfolio. Shares reduced by 5.95%
  5. Comcast Corp ( CMCSA ) - 531,671 shares, 4.72% of the total portfolio. Shares reduced by 7.57%

New Purchase: iShares Nasdaq Biotechnology Index Fund (IBB)

Spears Abacus Advisors LLC initiated holdings in iShares Nasdaq Biotechnology Index Fund. The purchase prices were between $246.87 and $293.09, with an estimated average price of $273.18. The stock is now traded at around $286.20. The impact to the portfolio due to this purchase was 0.16%. The holdings were 4,768 shares as of 2016-12-31.

New Purchase: Kellogg Co (K)

Spears Abacus Advisors LLC initiated holdings in Kellogg Co. The purchase prices were between $70.96 and $77.25, with an estimated average price of $74.06. The stock is now traded at around $75.52. The impact to the portfolio due to this purchase was 0.09%. The holdings were 9,157 shares as of 2016-12-31.

New Purchase: Kimberly-Clark Corp (KMB)

Spears Abacus Advisors LLC initiated holdings in Kimberly-Clark Corp. The purchase prices were between $112.15 and $124.76, with an estimated average price of $116.08. The stock is now traded at around $123.51. The impact to the portfolio due to this purchase was 0.08%. The holdings were 5,295 shares as of 2016-12-31.

New Purchase: Great Plains Energy Inc (GXP)

Spears Abacus Advisors LLC initiated holdings in Great Plains Energy Inc. The purchase prices were between $26.2 and $28.6, with an estimated average price of $27.33. The stock is now traded at around $27.94. The impact to the portfolio due to this purchase was 0.07%. The holdings were 20,198 shares as of 2016-12-31.

New Purchase: Mead Johnson Nutrition Co (MJN)

Spears Abacus Advisors LLC initiated holdings in Mead Johnson Nutrition Co. The purchase prices were between $70.69 and $80.96, with an estimated average price of $74.53. The stock is now traded at around $88.08. The impact to the portfolio due to this purchase was 0.07%. The holdings were 7,832 shares as of 2016-12-31.

New Purchase: Viacom Inc (VIAB)

Spears Abacus Advisors LLC initiated holdings in Viacom Inc. The purchase prices were between $34.49 and $38.86, with an estimated average price of $36.74. The stock is now traded at around $43.31. The impact to the portfolio due to this purchase was 0.04%. The holdings were 7,968 shares as of 2016-12-31.

Added: The Hershey Co (HSY)

Spears Abacus Advisors LLC added to the holdings in The Hershey Co by 239.15%. The purchase prices were between $94.63 and $104.44, with an estimated average price of $98.75. The stock is now traded at around $108.13. The impact to the portfolio due to this purchase was 0.07%. The holdings were 7,719 shares as of 2016-12-31.

Sold Out: Robert Half International Inc (RHI)

Spears Abacus Advisors LLC sold out the holdings in Robert Half International Inc. The sale prices were between $36.7 and $49.24, with an estimated average price of $42.83.

Sold Out: Abbott Laboratories (ABT)

Spears Abacus Advisors LLC sold out the holdings in Abbott Laboratories. The sale prices were between $37.6 and $43.5, with an estimated average price of $39.65.

Sold Out: Norwegian Cruise Line Holdings Ltd (NCLH)

Spears Abacus Advisors LLC sold out the holdings in Norwegian Cruise Line Holdings Ltd. The sale prices were between $35.53 and $45.14, with an estimated average price of $40.03.

Sold Out: Royal Caribbean Cruises Ltd (RCL)

Spears Abacus Advisors LLC sold out the holdings in Royal Caribbean Cruises Ltd. The sale prices were between $68.05 and $86.19, with an estimated average price of $78.71.

Sold Out: America Movil SAB de CV (AMX)

Spears Abacus Advisors LLC sold out the holdings in America Movil SAB de CV. The sale prices were between $11.25 and $13.39, with an estimated average price of $12.11.

Sold Out: Bed Bath & Beyond Inc (BBBY)

Spears Abacus Advisors LLC sold out the holdings in Bed Bath & Beyond Inc. The sale prices were between $38.67 and $48.08, with an estimated average price of $43.37.

Reduced: Allergan PLC (AGN)

Spears Abacus Advisors LLC reduced to the holdings in Allergan PLC by 26.75%. The sale prices were between $188.47 and $242.65, with an estimated average price of $207.16. The stock is now traded at around $247.86. The impact to the portfolio due to this sale was -1.08%. Spears Abacus Advisors LLC still held 101,654 shares as of 2016-12-31.

Reduced: WisdomTree Europe SmallCap Dividend Fund (DFE)

Spears Abacus Advisors LLC reduced to the holdings in WisdomTree Europe SmallCap Dividend Fund by 68.25%. The sale prices were between $51.8 and $55.7, with an estimated average price of $53.47. The stock is now traded at around $57.54. The impact to the portfolio due to this sale was -0.15%. Spears Abacus Advisors LLC still held 9,895 shares as of 2016-12-31.

Reduced: Vanguard FTSE Developed Markets (VEA)

Spears Abacus Advisors LLC reduced to the holdings in Vanguard FTSE Developed Markets by 45.18%. The sale prices were between $35.58 and $37.43, with an estimated average price of $36.47. The stock is now traded at around $38.40. The impact to the portfolio due to this sale was -0.14%. Spears Abacus Advisors LLC still held 34,590 shares as of 2016-12-31.

Reduced: Goldman Sachs Group Inc (GS)

Spears Abacus Advisors LLC reduced to the holdings in Goldman Sachs Group Inc by 64%. The sale prices were between $161.07 and $243.09, with an estimated average price of $203.06. The stock is now traded at around $246.90. The impact to the portfolio due to this sale was -0.08%. Spears Abacus Advisors LLC still held 2,040 shares as of 2016-12-31.

Reduced: Bristol-Myers Squibb Company (BMY)

Spears Abacus Advisors LLC reduced to the holdings in Bristol-Myers Squibb Company by 71.73%. The sale prices were between $49.23 and $59.61, with an estimated average price of $54.67. The stock is now traded at around $51.85. The impact to the portfolio due to this sale was -0.06%. Spears Abacus Advisors LLC still held 3,730 shares as of 2016-12-31.

Reduced: Vanguard Information Tech ETF - DNQ (VGT)

Spears Abacus Advisors LLC reduced to the holdings in Vanguard Information Tech ETF - DNQ by 38.78%. The sale prices were between $116.6 and $123.83, with an estimated average price of $120.57. The stock is now traded at around $131.34. The impact to the portfolio due to this sale was -0.05%. Spears Abacus Advisors LLC still held 5,350 shares as of 2016-12-31.

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GE CMCSA TMO AIG CB

Other Topics

Stocks

Latest Markets Videos